CacheBy
Thermo Fisher Scientific Erenumab Recombinant Human Monoclonal Antibody
원본

Thermo Fisher Scientific Erenumab Recombinant Human Monoclonal Antibody

상품 한눈에 보기

Erenumab 인간 단클론 항체로, CGRP 수용체를 표적으로 하는 편두통 연구용 항체입니다. CHO 세포 발현, Protein A 정제, 액상 형태로 제공됩니다. ELISA 등 연구용으로 사용되며, 장기 보관은 -20~-80°C에서 가능합니다.

카탈로그번호
MA542108
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 05. 오전 02:55
Thermo Fisher Scientific MA542108 Erenumab Recombinant Human Monoclonal Antibody 100 ug pk판매 단위 pk ·
재고 확인 필요
714,600원VAT 포함 786,060원

Thermo Fisher Scientific · Thermo Fisher Scientific Erenumab Recombinant Human Monoclonal Antibody

Applications

  • ELISA (ELISA): Assay-dependent

Product Specifications

항목 내용
Species Reactivity Human
Host / Isotype Human / IgG2, lambda
Expression System CHO cells
Class Recombinant Monoclonal
Type Antibody
Immunogen Human CALCRL/CGRP-R
Conjugate Unconjugated
Form Liquid
Concentration 1.12 mg/mL
Purification Protein A
Storage Buffer PBS, pH 7.5
Contains No preservative
Storage Conditions -20°C, Avoid Freeze/Thaw Cycles
Shipping Conditions Ambient (domestic); Wet ice (international)
RRID AB_2911251

Product Specific Information

  • Endotoxin level < 0.01 EU/µg (LAL method)
  • Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • Store at 2–8°C for one week or at -20 to -80°C for up to 12 months from the date of receipt.

Target Information

Erenumab (AMG-334) (INN; trade name Aimovig) is a human monoclonal antibody designed to bind and antagonize the calcitonin gene-related peptide receptor (CGRPR), a key mediator in migraine pathophysiology. This antibody represents a novel therapeutic approach, being the first FDA-approved treatment developed to prevent migraine by blocking the CGRP receptor.

For Research Use Only.
Not for use in diagnostic procedures.
Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.